Delivery Order 75N98020D00053-75N92024F00004

Award Date 12/20/23
Potential Completion Date 3/19/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60601, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Heart, Lung and Blood Institute, a component of the National Institutes of Health within the Department of Health and Human Services, issued a $14,915 firm fixed-price delivery order against its NIH Patent Legal Services indefinite-delivery/indefinite-quantity master contract. Under this order, Leydig, Voit & Mayer, Ltd. will draft a continuation-in-part patent application for the Institute pertaining to sabre catalysts containing fluorinated carbon chains for the delivery of...
The National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, awarded a $10,682.50 delivery order against the National Institutes of Health Patent Legal Services master IDIQ contract to Leydig, Voit & Mayer, LTD. to pursue patent rights in Europe for "Sabre Catalysts Containing Fluorinated Carbon Chains for Delivery of Metal-Free MRI Contrast Agents." Specifically, the firm will file a national stage application to extend patent protection...
The National Heart, Lung and Blood Institute, a component of the Department of Health and Human Services, awarded a $10,482.50 delivery order against the NIH Patent Legal Services master IDIQ contract to Leydig, Voit & Mayer, LTD. to file a national stage application in Japan. This will allow the NHLBI to pursue patent rights in sabre catalysts containing fluorinated carbon chains for delivery of metal-free MRI contrast agents, as described in the original solicitation. The work is to be...
The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded a $14,600 firm fixed price delivery order against the NIH Patent Legal Services master indefinite-delivery/indefinite-quantity contract to Leydig, Voit & Mayer, LTD. The delivery order requires the law firm to file a Patent Cooperation Treaty patent application to secure intellectual property protections for the invention described in research proposal E-035-2022-0-PCT-02. The period of...
The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded a $0 firm fixed price delivery order against the NIH Patent Legal Services master indefinite-delivery indefinite-quantity contract to Leydig, Voit & Mayer, LTD. to file a fully enabled provisional patent application with the United States Patent and Trademark Office. This action represents the first step for the NHLBI to obtain patent protection for an invention developed under the...
The National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, has awarded a $12,082.50 delivery order against the National Institutes of Health Patent Legal Services master IDIQ contract to Leydig, Voit & Mayer, LTD. to file a national stage application in China. This will allow the agency to pursue patent rights in sabre catalysts containing fluorinated carbon chains for delivery of metal-free MRI contrast agents, as originally required in the...
The National Heart, Lung and Blood Institute, a component of the Department of Health and Human Services, has awarded a $12,721 firm fixed price delivery order against the NIH Patent Legal Services master IDIQ contract to Leydig, Voit & Mayer, LTD. The delivery order requires the vendor to prepare and file a Patent Cooperation Treaty application combining the priority cases E-111-2022-0-US-01 and E-111-2022-1-US-01 in order to secure patent protection and claim priority for the invention...
The National Heart, Lung and Blood Institute, part of the National Institutes of Health within the Department of Health and Human Services, issued a $18,550 firm fixed price delivery order against the NIH Patent Legal Services master IDIQ contract to McDonnell Boehnen Hulbert & Berghoff LLP. Under this order, the firm will draft and file a Patent Cooperation Treaty application to secure international patent protection for an invention described in application E-188-2021-0-PCT-02. Work will...
The National Heart, Lung and Blood Institute, a component of the Department of Health and Human Services' National Institutes of Health, awarded a $12,170 delivery order against its NIH Patent Legal Services master IDIQ contract to Leydig, Voit & Mayer, LTD. to file a fully enabled provisional patent application with the United States Patent and Trademark Office for an employee invention. The contract has no set-aside designation and requires completion by March 31, 2022, with an award...
The National Heart, Lung and Blood Institute, part of the National Institutes of Health within the Department of Health and Human Services, awarded a $11,835 firm fixed price delivery order against the NIH Patent Legal Services master IDIQ contract to Leydig, Voit & Mayer, LTD. The delivery order requires the firm to prepare and file a national stage patent application with the European Patent Office to pursue international patent protection for an invention described in NIH reference number...

The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH), an agency of the Department of Health and Human Services (HHS), awarded a $10,395 firm fixed price delivery order against the NIH Patent Legal Services indefinite delivery/indefinite quantity master contract to Leydig, Voit & Mayer, LTD. The delivery order requires the law firm to file a national stage patent application in the United States from an existing Patent Cooperation Treaty application in order to pursue patent rights for sabre catalysts containing fluorinated carbon chains for the delivery of metal-free magnetic resonance imaging contrast agents. The work will be performed in Chicago, Illinois over a three-month period concluding in March 2024. No set aside designation or major subcontractors were noted.

Generated 12/22/23, 10:58 AM